Tonghua Golden-Horse shareholders approve key financial proposals

Tonghua Golden-Horse Pharmaceutical Industry Group held its fourth extraordinary general meeting of shareholders for 2025 on November 28, 2025, where all proposed resolutions were passed without any rejections. A total of 363 shareholders, representing 245,896,803 shares or 25.4421% of the company's total shares, participated.

Key resolutions approved included the reappointment of the company's auditing firm for 2025 and the forecasted guarantee limits for both subsidiaries to the parent company and the parent company to subsidiaries. The reappointment of the auditing firm received 99.8729% approval, with 245,584,303 votes in favor. The proposal regarding the forecast of guarantee limits for subsidiaries to the parent company was approved with 99.8560% of votes, totaling 245,542,703 shares.

Furthermore, the proposal concerning the forecast of guarantee limits for wholly-owned subsidiaries to the parent company garnered 99.8582% approval, with 245,548,203 votes. Legal opinions from Jilin Bence Law Firm confirmed the meeting's compliance with relevant laws and regulations, validating the legitimacy and effectiveness of the resolutions passed.